Al's Comment:

 This is exciting for the drug Onc-201.  The meeting is not for approval but for the FDA to learn about the drug and help guide the process to approval.  This is not done for most drugs.   

---

Posted on: 05/08/2019

Oncoceutics Invited to Present ONC201 at Public Advisory Committee Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee on June 20, 2019
  

 

---

Click HERE to return to brain tumor news headlines.